Impact of CD4 t cell count on the outcome of planned treatment interruptions in early-treated HIV infected children

Emilia Sánchez Ruiz, Clàudia Fortuny, Antoni Noguera-Julián, Laia Alsina, Rocío Bellido, Carmen Muñoz-Almagro, Lidia Ruiz

Producció científica: Article en revista indexadaArticleAvaluat per experts

Resum

The interferon-gamma release assays have greater specificity than the tuberculin skin test (TST), and at least equal sensitivity. We analyzed the sensitivity and specificity of the TST in immunocompetent children considering QuantiFERON as the referent standard. A TST cut-off
point of 5 mm indicates excellent sensitivity (100%) and specificity (93%) in children without Bacillus Calmette-Gue´rin. In Bacillus CalmetteGue´rin-vaccinated children, the TST cut-off point of 10 mm had poorer specificity (86%), and a cut-off point of 15 mm resulted in reduced sensitivity (60%).
Idioma originalAnglès
Pàgines (de-a)426-428
Nombre de pàgines3
RevistaPediatric Infectious Disease Journal
Volum30
Número5
Estat de la publicacióPublicada - 1 de maig 2011

Fingerprint

Navegar pels temes de recerca de 'Impact of CD4 t cell count on the outcome of planned treatment interruptions in early-treated HIV infected children'. Junts formen un fingerprint únic.

Com citar-ho